Staar Surgical (STAA) | Financial Analysis & Statements
Staar Surgical Company Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
57.8M
Gross Profit
43.7M
75.68%
Operating Income
-10.9M
-18.92%
Net Income
-18.3M
-31.68%
EPS (Diluted)
$-0.37
Balance Sheet Metrics
Total Assets
451.7M
Total Liabilities
107.5M
Shareholders Equity
344.2M
Debt to Equity
0.31
Cash Flow Metrics
Operating Cash Flow
-238.0K
Free Cash Flow
-5.6M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Staar Surgical Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 239.4M | 313.9M | 322.4M | 284.4M | 230.5M |
| Cost of Goods Sold | 57.0M | 74.3M | 69.8M | 61.0M | 51.8M |
| Gross Profit | 182.4M | 239.6M | 252.7M | 223.4M | 178.6M |
| Gross Margin % | 76.2% | 76.3% | 78.4% | 78.5% | 77.5% |
| Operating Expenses | |||||
| Research & Development | 40.1M | 54.0M | 44.4M | 36.0M | 33.9M |
| Selling, General & Administrative | 188.3M | 198.2M | 180.2M | 143.6M | 111.4M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 228.4M | 252.2M | 224.6M | 179.6M | 145.3M |
| Operating Income | -45.9M | -12.6M | 28.1M | 43.8M | 33.3M |
| Operating Margin % | -19.2% | -4.0% | 8.7% | 15.4% | 14.5% |
| Non-Operating Items | |||||
| Interest Income | 4.6M | 5.9M | - | - | - |
| Interest Expense | - | - | - | - | - |
| Other Non-Operating Income | -40.9M | -2.4M | -1.4M | -698.0K | -2.0M |
| Pre-tax Income | -82.3M | -9.1M | 33.7M | 45.6M | 31.3M |
| Income Tax | -1.8M | 11.2M | 12.3M | 5.9M | 3.8M |
| Effective Tax Rate % | 0.0% | 0.0% | 36.6% | 12.9% | 12.1% |
| Net Income | -80.4M | -20.2M | 21.3M | 39.7M | 27.5M |
| Net Margin % | -33.6% | -6.4% | 6.6% | 13.9% | 11.9% |
| Key Metrics | |||||
| EBITDA | 5.9M | -2.0M | 35.1M | 50.0M | 39.9M |
| EPS (Basic) | $-1.62 | $-0.41 | $0.44 | $0.81 | $0.52 |
| EPS (Diluted) | $-1.62 | $-0.41 | $0.43 | $0.79 | $0.50 |
| Basic Shares Outstanding | 49568000 | 49125000 | 48523000 | 47987000 | 47210000 |
| Diluted Shares Outstanding | 49568000 | 49125000 | 48523000 | 47987000 | 47210000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Staar Surgical Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 153.2M | 144.2M | 183.0M | 86.5M | 199.7M |
| Short-term Investments | 34.4M | 86.3M | 37.7M | 125.2M | 0 |
| Accounts Receivable | 50.1M | 77.9M | 94.7M | 62.4M | 43.5M |
| Inventory | 55.5M | 43.3M | 35.1M | 24.2M | 17.3M |
| Other Current Assets | 374.0K | 980.0K | 762.0K | 811.0K | 636.0K |
| Total Current Assets | 311.5M | 367.9M | 365.3M | 311.7M | 271.4M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 773.0K | 758.0K | 0 | 0 | 0 |
| Goodwill | 34.3M | 3.6M | 3.6M | 3.7M | 3.8M |
| Intangible Assets | 30.7M | - | - | 173.0K | 218.0K |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 4.7M | 18.0M | 8.5M | 9.7M | 4.6M |
| Total Non-Current Assets | 140.1M | 141.6M | 123.4M | 107.1M | 74.4M |
| Total Assets | 451.7M | 509.5M | 488.7M | 418.8M | 345.8M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 11.6M | 16.7M | 13.6M | 11.6M | 8.7M |
| Short-term Debt | 5.9M | 3.9M | 4.4M | 3.7M | 3.4M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 24.8M | 23.0M | 18.0M | 14.8M | 14.3M |
| Total Current Liabilities | 68.5M | 70.3M | 65.0M | 51.7M | 48.8M |
| Non-Current Liabilities | |||||
| Long-term Debt | 32.5M | 34.8M | 31.5M | 27.3M | 28.7M |
| Deferred Tax Liabilities | 0 | 297.0K | 1.1M | 1.5M | 811.0K |
| Other Non-Current Liabilities | - | - | - | - | - |
| Total Non-Current Liabilities | 39.0M | 41.9M | 37.7M | 31.0M | 38.4M |
| Total Liabilities | 107.5M | 112.2M | 102.7M | 82.7M | 87.2M |
| Equity | |||||
| Common Stock | 498.0K | 493.0K | 488.0K | 482.0K | 477.0K |
| Retained Earnings | -148.0M | -67.6M | -47.4M | -68.7M | -111.4M |
| Treasury Stock | 6.5M | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 344.2M | 397.3M | 386.0M | 336.1M | 258.6M |
| Key Metrics | |||||
| Total Debt | 38.4M | 38.7M | 35.8M | 31.0M | 32.1M |
| Working Capital | 243.0M | 297.6M | 300.2M | 260.0M | 222.6M |
Balance Sheet Composition
Staar Surgical Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -80.4M | -20.2M | 21.3M | 39.7M | 27.5M |
| Depreciation & Amortization | 8.7M | 6.9M | 5.1M | 4.5M | 3.6M |
| Stock-Based Compensation | 30.6M | 27.2M | 23.5M | 20.4M | 14.6M |
| Working Capital Changes | -15.0M | 10.0M | -37.4M | -26.3M | -1.7M |
| Operating Cash Flow | -55.4M | 27.4M | 15.7M | 36.0M | 42.6M |
| Investing Activities | |||||
| Capital Expenditures | -5.8M | -23.4M | -18.2M | -18.1M | -13.6M |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | -75.4M | -80.2M | -52.3M | -155.7M | 0 |
| Investment Sales | 127.5M | 44.4M | 144.8M | 17.5M | 0 |
| Investing Cash Flow | 46.3M | -59.2M | 74.3M | -156.4M | -13.6M |
| Financing Activities | |||||
| Share Repurchases | -8.0M | -1.5M | -2.1M | 0 | 0 |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | - | - | - | - |
| Debt Repayment | -42.0K | -165.0K | -161.0K | -126.0K | -1.6M |
| Financing Cash Flow | -8.0M | -1.7M | -2.3M | -125.0K | -2.9M |
| Free Cash Flow | -40.0M | -7.7M | -3.6M | 17.6M | 30.3M |
| Net Change in Cash | -17.1M | -33.5M | 87.8M | -120.5M | 26.0M |
Cash Flow Trend
Staar Surgical Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
49.73
Forward P/E
32.36
Price to Book
3.58
Price to Sales
5.15
PEG Ratio
-1.07
Profitability Ratios
Profit Margin
-33.60%
Operating Margin
-18.87%
Return on Equity
-21.70%
Return on Assets
-5.95%
Financial Health
Current Ratio
4.55
Debt to Equity
11.14
Beta
1.04
Per Share Data
EPS (TTM)
$-1.62
Book Value per Share
$6.97
Revenue per Share
$4.83
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| STAA | 1.2B | 49.73 | 3.58 | -21.70% | -33.60% | 11.14 |
| Intuitive Surgical | 170.1B | 54.97 | 8.99 | 16.69% | 28.38% | 0.95 |
| Becton, Dickinson | 56.1B | 25.40 | 1.75 | 6.96% | 8.01% | 77.28 |
| Pulse Biosciences | 1.6B | - | 20.17 | -74.45% | -54.00% | 9.34 |
| AtriCure | 1.4B | -117.54 | 2.77 | -2.40% | -2.14% | 15.54 |
| Anbio Biotechnology | 1.2B | 181.00 | 39.52 | 27.05% | 74.06% | 0.00 |
Financial data is updated regularly. All figures are in the company's reporting currency.






